Fagron US

What Fagron US does

Fagron US is the US operating subsidiary of Fagron NV (Euronext Brussels and Amsterdam: FAGR) and serves as the company's primary North American vehicle for pharmaceutical compounding. Founded in 1993 and headquartered in Austin, Texas, Fagron US supplies compounding pharmacies, hospitals, and clinics with the raw materials, formulations, equipment, sterile outsourcing, genomics testing, and education required to produce personalized medications. The business is organized around three commercial pillars: Fagron Brands (proprietary formulations including TrichoConcept with patented TrichoTech phytocomplex technology, Pentravan transdermal vehicles, and DiluCap excipients), Fagron Essentials (1,000+ APIs, capsules, chemicals, and supplies), and FagronLab (precision compounding equipment including the FagronLab Planetary Mixer PM-140, EMP/EMP Pro, 3-Roll Mill, InvoMatic, and Apo-Ident 2 NIR spectrometer). Supporting service lines include Fagron Sterile Services US, a 503B outsourcing operation with cGMP-compliant facilities in Boston, MA and Wichita, KS producing sterile preparations for hospitals; Fagron Genomics, a pharmacogenomic (PGx) and nutrigenomic (NGx) testing interpretation service; and Fagron Academy, a CE-accredited education platform that delivers compounding courses, SOP support, and regulatory compliance resources, notably in partnership with Gates Healthcare Associates.

The business model combines one-time product sales (APIs, formulations, capsules, equipment, hardware) with managed 503B outsourcing services and professional services revenue from genomics laboratory interpretation and education. GTM is sales-led, with direct customer service via a (800) 423-6967 line, an e-commerce storefront at shop.fagron.us, a FagronLab Service Center in St. Paul, MN, and active participation in compounding pharmacy trade shows (APC, ASHP, state pharmacy associations). Pricing is quote-based and not publicly disclosed; orders of at least US$ 250 ship free ground with net-30 payment terms. In February 2022, Fagron US acquired Letco Medical for US$ 34 million (adding approximately US$ 40 million in 2021 sales at ~11% EBITDA margin) and concurrently divested 80% of its US contract manufacturing business for approximately US$ 6 million, retaining a 20% minority interest and refocusing the US footprint on compounding brands, essentials, sterile services, genomics, and education.

Name

Fagron US

Legal name

Fagron, Inc.

Website

https://fagron.us

Company type

Public

Founded year

1993

Operating status

Operating

Headcount range

51–100 employees

Short description

Fagron US is the North American subsidiary of Fagron NV, supplying compounding pharmacies, hospitals, and clinics with APIs, proprietary formulations, precision compounding equipment, 503B sterile outsourcing, pharmacogenomic testing, and CE-accredited pharmacy education.

Ownership category

akta.pro rank

Product category

Pharmaceutical Compounding Supplies

NAICS

Pharmaceutical Preparation Manufacturing (325412), Pharmaceutical and Medicine Manufacturing (3254), Pharmaceutical and Medicine Manufacturing (32541), Analytical Laboratory Instrument Manufacturing (334516), Medical Equipment and Supplies Manufacturing (3391)

SIC

Pharmaceutical Preparations (2834), Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122), Wholesale-Medical, Dental & Hospital Equipment & Supplies (5047), Laboratory Analytical Instruments (3826), Services-Medical Laboratories (8071)

akta.pro primary industry

Compounding Pharmacies (Sterile/Non-Sterile) (HLAFALAE)

akta.pro secondary industries

Compounding Ingredient & API Distributors (Pharma Supply) (HLAIAJAO), Compounding Pharmacy & Sterile Prep Workflow Systems (HLACAKAM)

Keywords

• Pharmaceutical compounding
• Active pharmaceutical ingredients
• 503B sterile outsourcing
• Compounding pharmacy equipment
• Pharmacogenomic testing

Headquarters

HQ city

Austin, TX

HQ country

United States

HQ region

North America

Offices4 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Operations, Personnel, Technology or R&D, Marketing or Sales, Infrastructure

Revenue model

1. Pharmaceutical Compounding Products: Sale of proprietary compounding formulations, vehicles, and excipients (e.g., DiluCap, Pentravan®, TrichoConcept™) to compounding pharmacies and pharmacies.
2. Raw Materials & APIs: Sale of high-quality pharmaceutical active pharmaceutical ingredients (APIs), chemicals, capsules, and excipients to compounding pharmacies. Fagron offers 1,000+ APIs.
3. Compounding Equipment: Sale of FagronLab™ compounding equipment including planetary mixers, ointment mills, EMP systems, and NIR spectrometers to pharmacies.
4. Fagron Sterile Services (503B): 503B outsourcing services providing sterile medicines to hospitals and clinics across the United States, including Critical Care, Labor & Delivery, Ophthalmics, and Pain Management products. Produced at cGMP-compliant facilities in Boston, MA and Wichita, KS.
5. Fagron Academy Education Services: Continuing education (CE) accredited courses and membership programs for compounding pharmacists, including SOP and regulatory compliance services delivered in partnership with Gates Healthcare.
6. Fagron Genomics Laboratory Services: Laboratory services providing pharmacogenomic (PGx) and nutrigenomic (NGx) testing interpretation to healthcare professionals.

Pricing tiers

Go-to-market motion1 record

Distribution channels4 records

Marketing channels5 records

Core offering

Fagron US supplies compounding pharmacies, hospitals, and clinics across the United States with proprietary pharmaceutical compounding formulations (DiluCap, Pentravan, TrichoConcept), 1,000+ active pharmaceutical ingredients and excipients, FagronLab precision compounding equipment, cGMP-compliant 503B sterile outsourced medicines, Fagron Genomics pharmacogenomic and nutrigenomic testing, and Fagron Academy continuing education for compounding pharmacists. Operations are supported by manufacturing sites in Boston and Wichita, an equipment service center in St. Paul, and the 2022 acquisition of Letco Medical.

Product overview

Fagron US is a pharmaceutical compounding company offering an integrated portfolio of products and services for personalized medicine. The portfolio consists of three main pillars: (1) Fagron Brands — innovative formulations including DiluCap, Pentravan®, and TrichoConcept™ for specific therapeutic applications; (2) Fagron Essentials — APIs, capsules, excipients, equipment, and supplies; and (3) FagronLab equipment line including Planetary Mixers (PM-140), EMP/EMP Pro mortar and pestle systems, 3-Roll Ointment Mills, InvoMatic automated mixers, and Apo-Ident™ 2 NIR spectrometers. Supporting services include Fagron Genomics for pharmacogenomic testing, Fagron Sterile Services US (503B outsourcing facilities in Boston and Wichita), and Fagron Academy for pharmacy education. The company acquired Letco Medical in February 2022 to expand its US Brands & Essentials business.

Differentiator

Problem solved

Functional benefit

Brands

• FagronLab: Compounding equipment line featuring precision engineering for modern compounding pharmacies, including planetary mixers, ointment mills, and automated mixing systems
• Fagron Academy
• Fagron Genomics
• Fagron Sterile Services
• Fagron Brands
• Fagron Essentials
• Letco Medical

Products and services

• DiluCap Line of excipients specially developed for compounding capsule formulations with consistent final characteristics.
• Pentravan Transdermal dosage form offering advantages over conventional routes by avoiding first-pass metabolism, preventing gastrointestinal erosion, and providing sustained release with lower plasma level fluctuations.
• TrichoConcept First global line of multifunctional compounding vehicles built on patented TrichoTech phytocomplex technology, developed specifically for personalized alopecia treatment compounding.
• FagronLab Planetary Mixer PM-140 Entry-level planetary mixer with blade-free mixing and deaeration system for high-efficiency preparation of creams, gels, ointments, and liquids combining rapid homogenization and air removal in a single step.
• FagronLab EMP & EMP Pro Electronic mortar and pestle combining patented mixing blade and hygienic jar-as-final-packaging design, minimizing handling and contamination risk with mix volumes from 30mL to 2,000mL.
• FagronLab 3-Roll Mill Compact 3-roll milling system using three counter-rotating rollers to generate high shear force for optimal particle size reduction in creams, ointments, gels, and suspensions, producing uniformly dispersed smooth final products.
• FagronLab InvoMatic Fully automated 3-axis compounding mixer using oloid-inspired inversion motion and diffusive mixing for precise, repeatable blends across powders, liquids, and homeopathic formulations, accommodating standard compounding vessels from 30mL to 1,000mL in a closed contamination-safe environment.
• Apo-Ident 2 NIR Spectrometer Near-infrared spectrometer distributed by FagronLab for rapid raw material verification, supporting over 1,100 raw materials with precise reproducible identification in less than 5 seconds without altering or contaminating samples.
• Fagron Sterile Services US (503B Outsourcing) Globally integrated 503B outsourcing service for hospitals and clinics across the United States, producing high-quality sterile medicines through cGMP CFR 210 & 211 compliant facilities, specializing in Critical Care, Labor & Delivery, Ophthalmics, and Pain Management sterile preparations.
• Fagron Genomics Laboratory service providing pharmacogenomic (PGx) and nutrigenomic (NGx) testing interpretation with customizable genetics and laboratory reports for healthcare professionals, enabling DNA-based personalized treatment recommendations.
• Fagron Academy Educational platform providing CE-accredited courses, SOP development, and regulatory compliance services to compounding pharmacy members, including partnerships with Gates Healthcare Associates for navigating USP 795, 797, and 800 requirements.
• Fagron Essentials (APIs, Capsules, Equipment, Supplies) High-quality pharmaceutical raw materials, equipment, supplies, and technology for modern compounding pharmacists including over 1,000 active pharmaceutical ingredients (APIs), chemicals, capsule sizes and colors, equipment tools, and operational supplies.

Quantifiable outcome

• Letco Medical acquisition: approximately US$ 40 million in annual sales with ~11% EBITDA margin, acquired for US$ 34 million

Named customers3 records

Segments4 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature9 records

Partnerships

Six partnerships are on record, tiered core and minor.

• Gates Healthcare AssociatescoreImplementation/ SI/ Consulting Partner · 19 May 2023Fagron Academy partnered with Gates Healthcare Associates in May 2023 to provide SOP and regulatory compliance services to Fagron Academy members. Gates Healthcare, a pharmaceutical and healthcare consulting firm, offers extensive clinical, programmatic, and regulatory knowledge to help compounding pharmacies navigate new USP <795>, <797>, and <800> requirements. Fagron Academy members receive these services at an exclusively discounted price.
• Low Dose Naltrexone (LDN) Research TrustminorStrategic or Co-development Partner · 1 January 2023Fagron joined the LDN Research Trust as a 2023 Corporate Member to support research and education about Low Dose Naltrexone. The partnership aims to increase opportunities for pharmaceutical discoveries that may lead to enhanced patient care, supporting Fagron's mission to advance personalized medicine.
• Letco MedicalcoreStrategic or Co-development Partner · 2 February 2022Fagron acquired Letco Medical in February 2022 for US$ 34 million. Letco is a US-based supplier of pharmaceutical raw materials, supplies, and equipment for compounding with expected 2021 sales of approximately US$ 40 million and an EBITDA margin of approximately 11%. The acquisition strengthened Fagron's Brands & Essentials position in the United States, combining Letco's complementary product portfolio with Fagron's existing business.
• Alliance for Pharmacy Compounding (APC)coreGTM or Marketing PartnerFagron is a Corporate Patron Partner of the Alliance for Pharmacy Compounding. The partnership includes participation in EduCon Virtual continuing education events, the annual Owners Summit, and Compounders on Capitol Hill advocacy events. Fagron is featured in Corporate Patron Showcases and virtual booths.
• United States Pharmacopeia (USP)coreStrategic or Co-development PartnerFagron partners with USP at the annual Compounding Implementation Workshop, where Fagron leadership joins the USP Compounding Expert Committee panel to explore current trends, initiatives, and regulations for quality compounding. Fagron participates in developing strategies for improving the quality of compounding to enhance patient care.
• Diversify RX / Pharmacy Profit SummitminorGTM or Marketing PartnerFagron Academy partnered with Diversify RX to co-host the Pharmacy Profit Summit, an event focused on helping pharmacy owners grow profitability. Fagron serves as the summit host and provides educational content and tools to attendees.

Scale indicators8 records

Recent moves7 records

Expansion highlights6 records

Direct peers

• B&B Pharmaceuticals: US supplier of compounding ingredients, chemicals, and supplies to compounding pharmacies. Comparable to Fagron Essentials with focus on APIs and excipient distribution.
• Medisca: Global supplier of pharmaceutical compounding ingredients, equipment, and education. Closely comparable to Fagron US in serving compounding pharmacies with APIs, vehicles, and proprietary bases across multiple countries.
• QuVa Pharma: US-focused 503B outsourcing facility producing sterile compounded medications for hospitals. Direct peer to Fagron Sterile Services US across Critical Care, Labor & Delivery, Ophthalmics, and Pain Management product lines.
• PCCA (Professional Compounding Centers of America): US-based supplier of APIs, excipients, bases, equipment, and education to compounding pharmacies. Directly overlaps with Fagron US across nearly every product line including branded formulations, raw materials, and pharmacy training.
• Spectrum Pharmacy Products: US division of Spectrum Chemical supplying APIs, excipients, and compounding supplies to pharmacies. Competes directly with Fagron Essentials in the raw materials and compounding supply category.
• Wells Pharma: 503B outsourcing facility supplying sterile compounded preparations to hospitals and health systems. Comparable to Fagron Sterile Services in targeting hospital customers with outsourced sterile products.

Broad incumbents

• Cardinal Health: Large US pharmaceutical and medical products distributor and outsourcer operating across retail pharmacy, hospital, and specialty channels. Adjacent to Fagron US through its nuclear pharmacy and specialty distribution businesses.
• Cencora (formerly AmerisourceBergen): Major US pharmaceutical distributor with global operations supplying retail pharmacies, hospitals, and specialty pharmaceutical providers. Overlaps with Fagron US in wholesale drug distribution to compounding pharmacy customers.
• McKesson Corporation: Largest US pharmaceutical distributor serving retail pharmacies, hospitals, and health systems. Broader portfolio than Fagron US but competes in wholesale drug and supply distribution to institutional pharmacy customers.

Emerging players

• Stokes Healthcare: US compounding pharmacy and 503B outsourcing facility focused on sterile and non-sterile preparations. Smaller-scale peer to Fagron Sterile Services US with overlapping hospital customer base.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks6 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/fagron-us

Revenue estimate

Valuation estimate

Number of profiles

Profiles9 records

Subsidiaries3 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Fagron US